Work

SWOG S0354: A phase II trial of CNTO328, a monoclonal antibody against interleukin-6 (IL-6), in chemotherapy pretreated patients (pts) with castration- resistant prostate cancer (CRPC)

Year: 2009

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2009.27.15_suppl.5143

Authors: J. K. Pinski, B. Goldman, T. Dorff, P. Mack, P. Lara, P. van Veldhuizen, D. Quinn, M. H. Hussain, I. M. Thompson

Institutions: University of Southern California, University of Kansas, The University of Texas at San Antonio Health Science Center, University of Michigan, University of California, Davis

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2242227352

Cites:

Cited by: 5

Related to: 10